Global Health
Security

Antibiotics have long been used to treat and prevent infections. However, because of the misuse and overuse of antibiotics, pathogens are increasingly becoming drug-resistant, the rise of which is a growing threat to global health security. Antibiotic-resistant infections often require the use of alternative drugs that may be more expensive, more toxic, and less effective. As more pathogens become antibiotic-resistant, it can become more challenging to manage complications in patients undergoing treatments, such as chemotherapy, that weaken the immune system, or who undergo complex surgical procedures.

CAMRIS Global Health works to combat the development and spread of antimicrobial resistance (AMR) by:

• Supporting the development of national AMR strategies and plans.
• Providing technical guidance to stakeholders as they coordinate and implement AMR activities.
• Building the capacity of partners to conduct AMR testing in human, animal, and agricultural sectors.
• Strengthening supply chain systems to ensure the availability of diagnostic tests and antimicrobial drugs.
• Promoting antimicrobial stewardship.
• Sharing best practices and lessons learned via papers, forums, and networks.